McKee · Proceedings of the National Academy of Sciences of the United States of America 2023 · In vitro and transgenic mouse experimental study · n=?

Circadian clock protein BMAL1 broadly influences autophagy and endolysosomal function in astrocytes.

Cited 63 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Mechanism-based bench and animal (mouse) research

PubMed 37155839 · doi:10.1073/pnas.2220551120 · record verified 2026-08-30

What was done

Researchers evaluated the consequences of astrocyte-specific deletion of the circadian regulator BMAL1 on autophagy, endolysosome dynamics, and protein degradation. The study utilized in vitro Bmal1-deficient astrocyte cultures, in vivo electron microscopy of brains from astrocyte-specific Bmal1 knockout (aKO) mice, and transcriptomic profiling of isolated astrocytes from young and aged Bmal1 aKO mice.

What was found

In vitro, BMAL1-deficient astrocytes displayed increased endocytosis, elevated lysosome-dependent protein cleavage, and accumulation of LAMP1- and RAB7-positive organelles. In vivo, electron microscopy demonstrated an accumulation of autophagosome-like structures within astrocytes in aKO mouse brains. Transcriptional analysis revealed broad dysregulation of lysosomal pathways in young and aged aKO astrocytes that occurred independently of TFEB activation. No numerical effect sizes, variance estimates, or p-values were provided in the abstract.

Why it matters

These findings link the core circadian transcription factor BMAL1 to astrocytic waste-clearance and degradation pathways. This provides a potential cell-autonomous mechanism linking circadian disruption to endolysosomal dysfunction seen in aging and neurodegenerative diseases.

Limits

The study is restricted to in vitro and transgenic mouse models, leaving relevance to human physiology unconfirmed. The abstract omits sample sizes (n), quantitative effect sizes, and detailed statistical thresholds. The direct causal relationship between these cellular alterations and neurodegenerative disease outcomes was not established.

Cited by